Objective: To describe the clinical, chest imaging, pathological manifestations and therapeutic experience of human infection with A/H7N9 virus. Methods: The features of 15 laboratory-confirmed cases of human infection with A/H7N9 virus in Taizhou, Jiangsu Province were retrospectively analyzed. Results: The 15 patients with confirmed viral pneumonia included 12 males and 3 females, with a median age of 61 years(ranging from 33 to 81 years). Twelve patients had a history of exposure to the poultry trading places, or direct contact with ill/dead avian, while 3 patients denied exposure or contact. The most common initial symptoms were fever, coughing, and respiratory distress. The illness progressed rapidly to acute respiratory distress syndrome (ARDS). Lab tests showed normal (8 cases) or decreased (7 cases)white blood cell count , decreased (13 cases) lymphocyte count and proportion , increased creatine kinase (CK, 12 cases) and lactate dehydrogenase (LDH, 15 cases), and respiratory failure (13 cases). Chest radiographic examination showed that the most common features were inflammatory infiltration in the lung, with partial consolidation. The average time of the diagnosis with influenza viral nucleic acid and onset of an oral anti-influenza drug were 7.1 days and 6.5 days. All patients were treated by antiviral drugs (oral oseltamivir 150 mg q12 h and/or intravenous paramivir 600 mg qd), with mechanical ventilation in 9 cases, glucocorticoid therapy in 5 cases (intravenous methylprednisolone in 3 and dexamethasone in 2 patients), extracorporeal membrane oxygenation (ECMO) therapy in 2 cases, continuous renal replacement therapy (CRRT) in 6 cases, and artificial liver therapy in 1 case. The pulmonary pathology was observed from post-mortem biopsy for 2 fatal cases. Patient 1 had diffuse alveolar damage with inflammatory exudation, hyaline membrane formation, and cellular infiltration. Patient 2 had widened alveolar septum, lymphocyte and monocyte cell infiltration in the alveolar septa, and interstitial fibrous proliferation. Nine patients were discharged, and 6 died. Conclusions: Patients with influenza A/H7N9 virus mostly presented with fever, cough, and were prone to progression to viral pneumonia. Once acute respiratory distress and important organ dysfunction occurred, the fatality rate was higher. Early diagnosis and rational treatment were critical for better outcomes.
目的: 总结人感染H7N9禽流感病毒性肺炎患者的临床、影像、病理特征及治疗经验。 方法: 对2017年1—5月本院收治的15例人感染H7N9禽流感病毒性肺炎患者的临床资料进行回顾性分析。 结果: 15例中,男12例,女3例,年龄33~81岁,中位年龄61岁。其中12例有直接接触禽类或曾到过禽类交易场所史,3例无明确接触史。临床症状以发热、咳嗽为主,伴胸闷、气急,短期内进展为重症肺炎,并持续加重。白细胞计数正常8例,下降7例,淋巴细胞下降13例;肌酸激酶增高12例,乳酸脱氢酶增高15例;呼吸衰竭13例。肺部影像学以渗出性病变为主,部分实变。发病至流感病毒核酸检测阳性(确诊)的平均时间为7.1 d,发病至口服抗流感病毒药物治疗的平均时间为6.5 d。9例使用呼吸机辅助通气,15例入院后均给予奥司他韦(150 mg口服,1次/12 h)和(或)帕拉米韦(600 mg静脉滴注,1次/d);糖皮质激素治疗5例,其中甲泼尼龙3例,地塞米松2例;体外膜肺氧合(ECMO)治疗2例,连续性肾脏替代疗法(CRRT)治疗6例,人工肝治疗1例。6例死亡,其中2例在死亡后行经皮肺穿刺肺组织病理检查,病理见弥漫性肺泡损伤,炎性细胞浸润,肺泡腔内渗出明显,透明膜形成,间质性肺炎样病变,肺泡间隔增宽,间质内纤维组织增生,伴淋巴细胞和单核细胞浸润。9例治愈出院。 结论: H7N9禽流感患者发病早期以发热、咳嗽为主,容易进展为病毒性肺炎,应及早诊断及治疗;出现急性呼吸窘迫及重要脏器功能障碍时,病死率较高。.
Keywords: Influenza A virus; Influenzain in birds; Pneumonia, viral.